Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilla Stephens

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Pharmacogenetics and Genomics|May 21, 2016
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen allelesCamilla Stephens, Agustin Castiella, Eva M Gomez-Moreno, et al.
Gastroenterology|December 10, 2022
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-ClavulanatePaola Nicoletti, Andrew Dellinger, Yi Ju Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injuryMaria Mikus, Kimi Drobin, Marcus Gry, et al.
Archives of Toxicology|March 24, 2021
Serious liver injury induced by Nimesulide: an international collaborative studyFernando Bessone, Nelia Hernandez, Manuel Mendizabal, et al.
Journal of Hepatology|February 4, 2021
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI RegistryCamilla Stephens, Mercedes Robles-Diaz, Inmaculada Medina-Caliz, et al.
Clinical Pharmacology and Therapeutics|May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity ReactionsPaola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
Nature Communications|March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humansKodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Journal of Hepatology|May 18, 2016
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injuryInmaculada Medina-Caliz, Mercedes Robles-Diaz, Beatriz Garcia-Muñoz, et al.
Gastroenterology|May 17, 2011
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II allelesM Isabel Lucena, Mariam Molokhia, Yufeng Shen, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Pharmacogenetics and Genomics|May 21, 2016
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen allelesCamilla Stephens, Agustin Castiella, Eva M Gomez-Moreno, et al.
Gastroenterology|December 10, 2022
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-ClavulanatePaola Nicoletti, Andrew Dellinger, Yi Ju Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injuryMaria Mikus, Kimi Drobin, Marcus Gry, et al.
Archives of Toxicology|March 24, 2021
Serious liver injury induced by Nimesulide: an international collaborative studyFernando Bessone, Nelia Hernandez, Manuel Mendizabal, et al.
Journal of Hepatology|February 4, 2021
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI RegistryCamilla Stephens, Mercedes Robles-Diaz, Inmaculada Medina-Caliz, et al.
Clinical Pharmacology and Therapeutics|May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity ReactionsPaola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
Nature Communications|March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humansKodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Journal of Hepatology|May 18, 2016
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injuryInmaculada Medina-Caliz, Mercedes Robles-Diaz, Beatriz Garcia-Muñoz, et al.
Gastroenterology|May 17, 2011
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II allelesM Isabel Lucena, Mariam Molokhia, Yufeng Shen, et al.
Pageof 6